Keywords: novartis, delivers, strong, 1st-qtr, figures, line, analysts
Novartis delivers strong 1st-qtr figures, in line with analysts forecasts
Article | 22 April 2005
Novartis, Switzerland's leading drugmaker, has posted first-quarter 2005 group sales of $7.34 billion, a rise of 11% on the like, year-earlier period, or ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
